Severity
Moderate
FDA Drug recall · Reported December 4, 2019
Failed Stability Specifications: Product exceeds compendia and firm's specifications for iron content.
Avantor Performance Materials Inc recalled Potassium Phosphate, Monobasic, Crystal, NF, Multi-Compendial, Bulk Pharmaceutical Chemic… - a moderate-severity action.
Potassium Phosphate, Monobasic, Crystal, NF, Multi-Compendial, Bulk Pharmaceutical Chemic… was recalled by Avantor Performance Materials Inc in December 4, 2019. Reason: Failed Stability Specifications: Product exceeds compendia and firm's specifications for iron content.. Check the official notice for the remedy. Verify recall #D-0575-2020 with the FDA Drug before acting.
The recall
Avantor Performance Materials Inc issued this moderate-severity FDA Drug recall-Failed Stability Specifications: Product exceeds compendia and firm's specifications for iron content..
Sourced from official FDA Drug enforcement records. Verify recall #D-0575-2020 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Drug action (record #D-0575-2020) was formally reported on December 4, 2019, with the manufacturer initiating the action on October 30, 2019. It is classified under Moderate severity (Class II), with a current status of Terminated. Avantor Performance Materials Inc is listed as the recalling firm, operating out of Paris, KY. Federal records list the affected scope as a) 36 bottles; b) 85 bottles; c) 43 pails; d) 28 bottles and drums; e) 100 bottles and drums; f) 4 pails.
The documented reason for this recall is: Failed Stability Specifications: Product exceeds compendia and firm's specifications for iron content. Distribution data in the federal record shows the product reached: Nationwide in the USA, Canada, India, and Singapore. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 5 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 14,287 drugs & medications recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified moderate severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Moderate
Affected scope
a) 36 bottles; b) 85 bottles; c) 43 pails; d) 28 bottles and drums; e) 100 bottles and drums; f) 4 pails
Related Recalls
6
5 from same agency
Potassium Phosphate, Monobasic, Crystal, NF, Multi-Compendial, Bulk Pharmaceutical Chemical, packaged in a) 500G glass bottles, product number 3248-01, NDC 10106-3248-1; b) 2.5KG glass bottles, product number 3248-05, NDC 10106-3248-2; c) 12KG pails, product number 3248-07, NDC 10106-3248-3; d) 1KT bottles and drums, product number 3248-X2; e) 1KT bottles and drums, product number 3248-X3; f) 12KG pails, product number 7390-19; Avantor Performance Materials, LLC, 100 Matsonford, Road, Suite 200, Radnor, PA 19087.
Failed Stability Specifications: Product exceeds compendia and firm's specifications for iron content.
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Moderate (Class II) |
| Status | Terminated |
| Recall number | D-0575-2020 |
| Date reported | December 4, 2019 |
| Date initiated | October 30, 2019 |
| Recalling firm | Avantor Performance Materials Inc |
| Firm location | Paris, KY |
| Affected scope | a) 36 bottles; b) 85 bottles; c) 43 pails; d) 28 bottles and drums; e) 100 bottles and drums; f) 4 pails |
| Distribution | Nationwide in the USA, Canada, India, and Singapore |
Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
AbbVie Inc. · 2026-06-03
Llorens Pharmaceuticals International Division, Inc. · 2026-05-27
Safecor Health, LLC · 2026-05-27
IntegraDose Compounding Services LLC · 2026-05-27
Lupin Pharmaceuticals Inc. · 2026-05-27
Compare this recall with PRED MILD, prednisolone acetate ophthalmic suspension, USP,… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported December 4, 2019. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.